Literature DB >> 17409055

Borderline personality disorder and dissociation.

Colin A Ross1.   

Abstract

This study examined the dissociative comorbidity reported by psychiatric inpatients with and without borderline personality disorder. The Dissociative Disorders Interview Schedule and Dissociative Experiences Scale were administered to 201 general adult psychiatric inpatients; of these, 110 also received the Structured Clinical Interview for DSM-IV-TR Dissociative Disorders. The patients were then divided into two groups--a group of 93 who met criteria for borderline personality disorder on the Dissociative Disorders Interview Schedule and 108 who did not. The two groups were then compared on dissociative symptoms and disorders. The inpatients with borderline personality disorder reported significantly more dissociative symptoms and disorders on all measures. On the Dissociative Disorders Interview Schedule, 59% of the borderline patients met criteria for a dissociative disorder compared with 22% of the non-borderline patients. Chronic, complex dissociative symptoms and disorders are common in borderline personality disorder. The ninth DSM-IV-TR criterion for borderline personality disorder does not adequately describe the dissociative comorbidity in the disorder.

Entities:  

Mesh:

Year:  2007        PMID: 17409055     DOI: 10.1300/J229v08n01_05

Source DB:  PubMed          Journal:  J Trauma Dissociation        ISSN: 1529-9732


  11 in total

Review 1.  The Application of an Etiological Model of Personality Disorders to Problem Gambling.

Authors:  Meredith Brown; J Sabura Allen; Nicki A Dowling
Journal:  J Gambl Stud       Date:  2015-12

2.  A comprehensive examination of delayed emotional recovery in borderline personality disorder.

Authors:  Skye Fitzpatrick; Janice R Kuo
Journal:  J Behav Ther Exp Psychiatry       Date:  2014-11-18

Review 3.  Dissociation and borderline personality disorder: an update for clinicians.

Authors:  Marilyn I Korzekwa; Paul F Dell; Clare Pain
Journal:  Curr Psychiatry Rep       Date:  2009-02       Impact factor: 5.285

4.  Levels of Depersonalization and Derealization Reported by Recovered and Non-recovered Borderline Patients Over 20 Years of Prospective Follow-up.

Authors:  Ravi Shah; Christina M Temes; Frances R Frankenburg; Garrett M Fitzmaurice; Mary C Zanarini
Journal:  J Trauma Dissociation       Date:  2020-01-30

5.  Coping strategies, hope, and treatment efficacy in pharmacoresistant inpatients with neurotic spectrum disorders.

Authors:  Marie Ociskova; Jan Prasko; Dana Kamaradova; Ales Grambal; Petra Kasalova; Zuzana Sigmundova; Klara Latalova; Kristyna Vrbova
Journal:  Neuropsychiatr Dis Treat       Date:  2015-05-15       Impact factor: 2.570

6.  Quality of life in borderline patients comorbid with anxiety spectrum disorders - a cross-sectional study.

Authors:  Ales Grambal; Jan Prasko; Dana Kamaradova; Klara Latalova; Michaela Holubova; Zuzana Sedláčková; Radovan Hruby
Journal:  Patient Prefer Adherence       Date:  2016-08-01       Impact factor: 2.711

Review 7.  Separating Fact from Fiction: An Empirical Examination of Six Myths About Dissociative Identity Disorder.

Authors:  Bethany L Brand; Vedat Sar; Pam Stavropoulos; Christa Krüger; Marilyn Korzekwa; Alfonso Martínez-Taboas; Warwick Middleton
Journal:  Harv Rev Psychiatry       Date:  2016 Jul-Aug       Impact factor: 3.732

Review 8.  Chronic complex dissociative disorders and borderline personality disorder: disorders of emotion dysregulation?

Authors:  Bethany L Brand; Ruth A Lanius
Journal:  Borderline Personal Disord Emot Dysregul       Date:  2014-10-14

9.  Individual correlates of self-stigma in patients with anxiety disorders with and without comorbidities.

Authors:  Marie Ociskova; Jan Prasko; Dana Kamaradova; Ales Grambal; Zuzana Sigmundova
Journal:  Neuropsychiatr Dis Treat       Date:  2015-07-17       Impact factor: 2.570

10.  Psychological factors and treatment effectiveness in resistant anxiety disorders in highly comorbid inpatients.

Authors:  Marie Ociskova; Jan Prasko; Klara Latalova; Dana Kamaradova; Ales Grambal
Journal:  Neuropsychiatr Dis Treat       Date:  2016-06-24       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.